|Bid||0.0000 x 2200|
|Ask||0.0000 x 21500|
|Day's Range||1.8100 - 1.8900|
|52 Week Range||0.7500 - 2.4000|
|Beta (5Y Monthly)||1.69|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
The big shareholder groups in Geron Corporation (NASDAQ:GERN) have power over the company. Large companies usually...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes.
Geron (GERN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.